Literature DB >> 27165242

Apoptotic Effects of the B Subunit of Bacterial Cytolethal Distending Toxin on the A549 Lung Cancer Cell Line.

Hajar Yaghoobi1, Mojgan Bandehpour, Bahram Kazemi.   

Abstract

Cytolethal distending toxin (CDT) is a secreted tripartite genotoxin produced by many pathogenic gram-negative bacteria. It is composed of three subunits, CdtA, CdtB and CdtC, and CdtB-associated deoxyribonuclease (DNase) activity is essential for the CDT toxicity. In the present study, to design a novel potentially antitumor drug against lung cancer, the possible mechanisms of cdtB anticancer properties were explored in the A549 human lung adenocarcinoma cell line. A recombinant plasmid pcDNA3.1/cdtB was constructed expressing CdtB of human periodontal bacterium Aggregatibacter actinomycetemcomitans and investigated for toxic properties in A549 cells and possible mechanisms. It was observed that plasmid pcDNA3.1/cdtB caused loss of cell viability, morphologic changes and induction of apoptosis. Furthermore, measurement of caspase activity indicated involvement of an intrinsic pathway of cell apoptosis. Consequently, the recombinant plasmid pcDNA3.1/cdtB may have potential as a new class of therapeutic agent for gene therapy of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27165242     DOI: 10.7314/apjcp.2016.17.s3.299

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

Review 1.  Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.

Authors:  Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan
Journal:  Respir Res       Date:  2021-04-29

2.  LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.

Authors:  Xuexue Xu; Pengsheng Ding; Lan Shi; Gang Wu; Xiaoling Ma
Journal:  BMC Cancer       Date:  2022-06-08       Impact factor: 4.638

Review 3.  Role of the Microbiota in Lung Cancer: Insights on Prevention and Treatment.

Authors:  Federica Pizzo; Zaira Maroccia; Ivano Hammarberg Ferri; Carla Fiorentini
Journal:  Int J Mol Sci       Date:  2022-05-30       Impact factor: 6.208

Review 4.  Human Lung Microbiome on the Way to Cancer.

Authors:  Olga V Kovaleva; Daniil Romashin; Irina B Zborovskaya; Mikhail M Davydov; Murat S Shogenov; Alexei Gratchev
Journal:  J Immunol Res       Date:  2019-07-29       Impact factor: 4.818

Review 5.  Implications of the Immune Landscape in COPD and Lung Cancer: Smoking Versus Other Causes.

Authors:  Elisabeth Taucher; Iurii Mykoliuk; Joerg Lindenmann; Freyja-Maria Smolle-Juettner
Journal:  Front Immunol       Date:  2022-03-21       Impact factor: 7.561

Review 6.  Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms.

Authors:  Nana Xu; Lei Wang; Chenxi Li; Chao Ding; Cong Li; Wenting Fan; Chen Cheng; Bing Gu
Journal:  Transl Lung Cancer Res       Date:  2020-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.